BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 31767270)

  • 1. Cardio-oncology in clinical studies and real life.
    Dent SF; Suter TM; López-Fernández T; Opolski G; Menna P; Minotti G
    Semin Oncol; 2019 Dec; 46(6):421-425. PubMed ID: 31767270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardio-oncological management of patients.
    Cardinale DM; Barac A; Torbicki A; Khandheria BK; Lenihan D; Minotti G
    Semin Oncol; 2019 Dec; 46(6):408-413. PubMed ID: 31784042
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms and clinical course of cardiovascular toxicity of cancer treatment I. Oncology.
    Yeh ETH; Ewer MS; Moslehi J; Dlugosz-Danecka M; Banchs J; Chang HM; Minotti G
    Semin Oncol; 2019 Dec; 46(6):397-402. PubMed ID: 31753424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Strategies to Prevent Cardiotoxicity.
    Graffagnino J; Kondapalli L; Arora G; Hawi R; Lenneman CG
    Curr Treat Options Oncol; 2020 Apr; 21(4):32. PubMed ID: 32270293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms and clinical course of cardiovascular toxicity of cancer treatment II. Hematology
    Breccia M; Carver JR; Szmit S; Jurczak W; Salvatorelli E; Minotti G
    Semin Oncol; 2019 Dec; 46(6):403-407. PubMed ID: 31748121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Helping the cardio-oncologist: from real life to guidelines.
    Armenian SH; Jurczak W; Carver JR; Gennari A; Minotti G; Ewer MS
    Semin Oncol; 2019 Dec; 46(6):433-436. PubMed ID: 31784041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular events in cancer survivors.
    Howard E; Steingart RM; Armstrong GT; Lyon AR; Armenian SH; Teresa Voso M; Cicconi L; Coco FL; Minotti G
    Semin Oncol; 2019 Dec; 46(6):426-432. PubMed ID: 31791551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Old and new directions of Cardio-Oncology.
    Ewer MS; Carver JR; Minotti G
    Semin Oncol; 2019 Dec; 46(6):395-396. PubMed ID: 31767271
    [No Abstract]   [Full Text] [Related]  

  • 9. Treatment specific toxicities: Hormones, antihormones, radiation therapy.
    Plummer C; Steingart RM; Jurczak W; Iakobishvili Z; Lyon AR; Plastaras JP; Minotti G
    Semin Oncol; 2019 Dec; 46(6):414-420. PubMed ID: 31784040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardio-oncology: a multidisciplinary approach for detection, prevention and management of cardiac dysfunction in cancer patients.
    Tajiri K; Aonuma K; Sekine I
    Jpn J Clin Oncol; 2017 Aug; 47(8):678-682. PubMed ID: 28505345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardio-oncology: conflicting priorities of anticancer treatment and cardiovascular outcome.
    Tilemann LM; Heckmann MB; Katus HA; Lehmann LH; Müller OJ
    Clin Res Cardiol; 2018 Apr; 107(4):271-280. PubMed ID: 29453595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardio-oncology: an ongoing evolution.
    Petek BJ; Greenman C; Herrmann J; Ewer MS; Jones RL
    Future Oncol; 2015; 11(14):2059-66. PubMed ID: 26198836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rationale and design of the multidisciplinary team IntervenTion in cArdio-oNcology study (TITAN).
    Pituskin E; Haykowsky M; McNeely M; Mackey J; Chua N; Paterson I
    BMC Cancer; 2016 Sep; 16(1):733. PubMed ID: 27629548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimizing cardio-oncology programs for cancer patients.
    Francis SA; Asnani A; Neilan T; Scherrer-Crosbie M
    Future Oncol; 2015; 11(14):2011-5. PubMed ID: 26198828
    [No Abstract]   [Full Text] [Related]  

  • 15. Report on the international colloquium on cardio-oncology (rome, 12-14 march 2014).
    Ewer M; Gianni L; Pane F; Sandri MT; Steiner RK; Wojnowski L; Yeh ET; Carver JR; Lipshultz SE; Minotti G; Armstrong GT; Cardinale D; Colan SD; Darby SC; Force TL; Kremer LC; Lenihan DJ; Sallan SE; Sawyer DB; Suter TM; Swain SM; van Leeuwen FE
    Ecancermedicalscience; 2014; 8():433. PubMed ID: 24932213
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular toxicity of anticancer-targeted therapy: emerging issues in the era of cardio-oncology.
    Raschi E; De Ponti F
    Intern Emerg Med; 2012 Apr; 7(2):113-31. PubMed ID: 22161318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How to Develop a Cardio-Oncology Clinic.
    Snipelisky D; Park JY; Lerman A; Mulvagh S; Lin G; Pereira N; Rodriguez-Porcel M; Villarraga HR; Herrmann J
    Heart Fail Clin; 2017 Apr; 13(2):347-359. PubMed ID: 28279420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological foundations of cardio-oncology.
    Minotti G; Salvatorelli E; Menna P
    J Pharmacol Exp Ther; 2010 Jul; 334(1):2-8. PubMed ID: 20335321
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardio-Oncology: An Update on Cardiotoxicity of Cancer-Related Treatment.
    Lenneman CG; Sawyer DB
    Circ Res; 2016 Mar; 118(6):1008-20. PubMed ID: 26987914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiotoxicities of 5-Fluorouracil and Other Fluoropyrimidines.
    Shiga T; Hiraide M
    Curr Treat Options Oncol; 2020 Mar; 21(4):27. PubMed ID: 32266582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.